Search research articles
Contact Us
Filters
Showing results (61-70 of 110) with videos related to
Page
of 11
Sort By:
Pharmacoepidemiology and Drug Safety
|
November 14, 2025
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (SNDS)
Astrid Coste, Angel Y S Wong, François Haguinet, et al.
Pharmacoepidemiology and Drug Safety
|
November 11, 2025
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using Merative MarketScan Research Databases
Astrid Coste, Angel Y S Wong, Francois Haguinet, et al.
Drug Safety
|
January 19, 2013
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance
Xiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar, et al.
Nature Reviews. Drug Discovery
|
August 7, 2023
Trustworthy AI for safe medicines
Jens-Ulrich Stegmann, Rory Littlebury, Markus Trengove, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact
Jeremy P Brown, Ian J Douglas, Shahid Hanif, et al.
Drug Safety
|
August 3, 2023
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility
Vijay Kara, Greg Powell, Olivia Mahaux, et al.
International Journal of Neural Systems
|
July 14, 2005
A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets
Roland Orre, Andrew Bate, G Niklas Norén, et al.
Drug Safety
|
December 7, 2023
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
Guojun Dong, Andrew Bate, François Haguinet, et al.
Journal of Cancer Policy
|
April 28, 2023
The role of Real-World Data and evidence in oncology medicines approved in EU in 2018-2019
Sini M Eskola, Hubertus G M Leufkens, Andrew Bate, et al.
Drug Safety
|
March 8, 2025
Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?
Lucinda Smith, Michael Glaser, Dieter Kempf, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 110) with videos related to
Sort By:
Page
of 11
Pharmacoepidemiology and Drug Safety
|
November 14, 2025
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (SNDS)
Astrid Coste, Angel Y S Wong, François Haguinet, et al.
Pharmacoepidemiology and Drug Safety
|
November 11, 2025
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using Merative MarketScan Research Databases
Astrid Coste, Angel Y S Wong, Francois Haguinet, et al.
Drug Safety
|
January 19, 2013
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance
Xiaofeng Zhou, Sundaresan Murugesan, Harshvinder Bhullar, et al.
Nature Reviews. Drug Discovery
|
August 7, 2023
Trustworthy AI for safe medicines
Jens-Ulrich Stegmann, Rory Littlebury, Markus Trengove, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 28, 2021
Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact
Jeremy P Brown, Ian J Douglas, Shahid Hanif, et al.
Drug Safety
|
August 3, 2023
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility
Vijay Kara, Greg Powell, Olivia Mahaux, et al.
International Journal of Neural Systems
|
July 14, 2005
A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets
Roland Orre, Andrew Bate, G Niklas Norén, et al.
Drug Safety
|
December 7, 2023
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing
Guojun Dong, Andrew Bate, François Haguinet, et al.
Journal of Cancer Policy
|
April 28, 2023
The role of Real-World Data and evidence in oncology medicines approved in EU in 2018-2019
Sini M Eskola, Hubertus G M Leufkens, Andrew Bate, et al.
Drug Safety
|
March 8, 2025
Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?
Lucinda Smith, Michael Glaser, Dieter Kempf, et al.
Page
of 11